Introduction The increasing incidence of type 2 diabetes mellitus (T2DM) among women of reproductive age poses significant health risks for both mothers and their fetuses. Optimising blood glucose ...

Hydroxychloroquine does not increase the risk of arrhythmia, a large study in Arthritis & Rheumatology has found. The study was precipitated by controversy surrounding hydroxychloroquine and a ...

Iowans will be able to weigh in on the bill during a public subcommittee hearing scheduled for Tuesday at 12:15 p.m. in Room ...

Current use of hydroxychloroquine is associated with a lower risk for myocardial infarction (MI), stroke, and other thromboembolic events in patients with systemic lupus erythematosus (SLE). This ...

A new study found a connection between lower doses of hydroxychloroquine (HCQ) and increased risk of hospitalization in people with active systemic lupus erythematosus (SLE). HCQ (known commercially ...

A discredited study that set off a flurry of interest in using an antimalarial drug to treat COVID-19 has now been formally withdrawn. A scientific journal on Tuesday retracted the March 2020 study ...

The optimal hydroxychloroquine blood level in lupus is between 750 ng/mL and 1,150 ng/mL, which can help prevent active ...

A recent study found that regularly checking blood levels of hydroxychloroquine (HCQ, known commercially as Plaquenil®) may reduce the need for emergency room visits and hospitalizations for people ...

Hydroxychloroquine use may lower the risk for new-onset diabetes among patients with primary Sjögren syndrome. Hydroxychloroquine (HCQ) use significantly lowers the risk for new-onset diabetes among ...

BENGALURU (Reuters) - India has lifted an export ban on hydroxychloroquine, the anti-malarial drug touted by U.S. President Donald Trump as a potential "game changer" in the fight against the COVID-19 ...